Pulmonary ECs of COVID-19 patients show increased expression of pro-coagulant vWf and decreased expression of the anticoagulants thrombomodulin (TM) and endothelial protein C receptor (EPCR) [152]. The gene discussed is PROCR; the disease is COVID-19.